Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study Comparing the Bioavailability of TAS-102 Tablets to an Oral Solution Containing Equivalent Amounts of FTD and TPI

This study has been completed.
Information provided by (Responsible Party):
Taiho Oncology, Inc. Identifier:
First received: June 4, 2013
Last updated: December 21, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2015
  Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)